Featured Products
Latest News
Mar
15
Liquid Biopsies for the Early Detection of Lung Cancer
The Fight Against Lung Cancer Developments in liquid biopsies provide significant implications in the advancement of care for patients with lung cancer. Lung cancer currently stands as the leading cause […]
We are ISO 9001 & 13485 Registered
Custom Sample Collection & Services
Product Release
BioChain launched CancerSeqPlus: NGS-characterized FFPE Tumor Samples. BioChain has leveraged NGS technologies to provide our customers with annotated reports of copy number variations (CNVs), single-nucleotide polymorphisms (SNPs), and insertions and deletion (indels) in clinically identified formalin fixed paraffin embedded (FFPE) tumor tissues.
Who We Are
For over 20 yrs BioChain had been committed to empowering researcher with high quality biospecimens, tools for sample preparation and analysis, and bio-assays to accelerate the development and commercialization of diagnostics, therapeutics and medicine.
